Recently, whole genome sequencing approaches have pinpointed mutations in genes that were previously not associated with cancer. For Acute Myeloid Leukaemia (AML), and other myeloid disorders, these approaches revealed a high prevalence of mutations in genes encoding the chromosome cohesion complex, cohesin. Cohesin mutations represent a novel genetic pathway for AML, but how AML arises from these mutations is unknown. This review will explore the potential mechanisms by which cohesin mutations contribute to AML and other myeloid malignancies. © 2014 Leeke et al.; licensee BioMed Central Ltd.
CITATION STYLE
Leeke, B., Marsman, J., O’Sullivan, J. M., & Horsfield, J. A. (2014, May 8). Cohesin mutations in myeloid malignancies: Underlying mechanisms. Experimental Hematology and Oncology. BioMed Central Ltd. https://doi.org/10.1186/2162-3619-3-13
Mendeley helps you to discover research relevant for your work.